MJ And MSOS: Cannabis’ Inevitable Legalization Offers High Upside Despite Blunt Risks
Cannabis legalization is inevitable, driven by shifting political and fiscal dynamics. Read why upside for cannabis ETFs like MJ and MSOS is compelling.
Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market
Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.
Deadline missed- Marijuana market reform could come back during veto session with hemp regulations
Canadian Indigenous leader says he was ‘filled with rage’ before ‘intense’ conversation with Trump US aircraft carrier USS George Washington counters China navy presence Singer performs US national …
Why Curaleaf Stock Blasted Almost 5% Higher Today
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium …
Marijuana industry debt crisis intensifies as lenders circle overleveraged operators
An overleveraged marijuana operator is resorting to what observers say are increasingly creative and desperate methods to avoid liquidation.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Cannabis stocks rally as Trump reportedly weighs rescheduling
Canadian cannabis stocks surge as Trump considers rescheduling marijuana as a less dangerous drug under the Controlled Substances Act. Read more here.
Retail Bulls Pile Into Cannabis Stocks On Reports Trump May Reclassify Marijuana; Traders Eye Aurora Rally
Canopy Growth (CGC), Cronos Group (CRON) and Trulieve Cannabis (TCNNF) after reports that U.S. President Donald Trump may reclassify marijuana as a less dangerous drug. The Wall Street Journal said …
Trump debates on reclassifying marijuana as less dangerous drug, WSJ says
President Donald Trump is debating on reclassifying marijuana as a less dangerous drug, Josh Dawsey of The Wall Street Journal reports, citing …
Trump eyes reclassifying marijuana as less dangerous drug: report
President Donald Trump is reportedly eyeing reclassifying marijuana as a less dangerous drug, a move that could expand medical marijuana research and ease industry restrictions. At a …
Why Curaleaf Holdings Stock Topped the Market Today
Two developments in the medical marijuana segment were encouraging for the pot company. While neither will be a game-changer on its own, they do represent progress for the marijuana sector more …
Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?
Corbus Pharmaceuticals CRBP is not your typical cannabis stock involved in cultivation, processing, or sales of marijuana products. Instead, this clinical-stage company is focused on developing …
Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are … – Benzinga
Four Marijuana Stocks Worth Watching. Despite his bearish view of the broader market, Kass said a select few companies remain attractive, particularly for long-term investors with patience.
To Save America’s Youth, Lawmakers Should Invest in Drug Prevention | Opinion
To maximize their effectiveness, drug prevention programs must reach adolescents before they are exposed to substance use in their peer groups.
After court ruling, APD says it won’t cite people for small amounts of marijuana — for now
When an appeals court struck down Austin’s marijuana decriminalization ordinance late last month, confusion and disappointment flooded social media. “So am I a criminal now?” Reddit user Environmental …
Recent Comments